DOTA-TOC in Metastasized Neuroendocrine Tumors

Clinical trial NCT00978211 · COMPLETED

Trial details

NCT number: NCT00978211
Sponsor: University Hospital, Basel, Switzerland
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 1997-09-01
Primary completion: 2013-09-01
Enrollment: 1499

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.